The/DT
peri-kappa/NN
B/NN
site/NN
mediates/VBZ
human/JJ
immunodeficiency/NN
virus/NN
type/NN
2/CD
enhancer/NN
activation/NN
in/IN
monocytes/NNS
but/CC
not/RB
in/IN
T/NN
cells/NNS
./.

Human/JJ
immunodeficiency/NN
virus/NN
type/NN
2/CD
(/(
HIV-2/NN
)/)
,/,
like/IN
HIV-1/NN
,/,
causes/VBZ
AIDS/NN
and/CC
is/VBZ
associated/VBN
with/IN
AIDS/NN
cases/NNS
primarily/RB
in/IN
West/NNP
Africa/NNP
./.
=====
HIV-1/NN
and/CC
HIV-2/NN
display/VBP
significant/JJ
differences/NNS
in/IN
nucleic/JJ
acid/NN
sequence/NN
and/CC
in/IN
the/DT
natural/JJ
history/NN
of/IN
clinical/JJ
disease/NN
./.
=====
Consistent/JJ
with/IN
these/DT
differences/NNS
,/,
we/PRP
have/VBP
previously/RB
demonstrated/VBN
that/IN
the/DT
enhancer/promoter/NN
region/NN
of/IN
HIV-2/NN
functions/VBZ
quite/RB
differently/RB
from/IN
that/DT
of/IN
HIV-1/NN
./.
=====
Whereas/IN
activation/NN
of/IN
the/DT
HIV-1/NN
enhancer/NN
following/VBG
T-cell/NN
stimulation/NN
is/VBZ
mediated/VBN
largely/RB
through/IN
binding/NN
of/IN
the/DT
transcription/NN
factor/NN
NF-kappa/NN
B/NN
to/TO
two/CD
adjacent/JJ
kappa/NN
B/NN
sites/NNS
in/IN
the/DT
HIV-1/NN
long/JJ
terminal/JJ
repeat/NN
,/,
activation/NN
of/IN
the/DT
HIV-2/NN
enhancer/NN
in/IN
monocytes/NNS
and/CC
T/NN
cells/NNS
is/VBZ
dependent/JJ
on/IN
four/CD
cis-acting/JJ
elements/NNS
:/:
a/DT
single/JJ
kappa/NN
B/NN
site/NN
,/,
two/CD
purine-rich/JJ
binding/VBG
sites/NNS
,/,
PuB1/NN
and/CC
PuB2/NN
,/,
and/CC
a/DT
pets/NN
site/NN
./.
=====
We/PRP
have/VBP
now/RB
identified/VBN
a/DT
novel/JJ
cis-acting/JJ
element/NN
within/IN
the/DT
HIV-2/NN
enhancer/NN
,/,
immediately/RB
upstream/JJ
of/IN
the/DT
kappa/NN
B/NN
site/NN
,/,
designated/VBN
peri-kappa/NN
B/NN
./.
=====
This/DT
site/NN
is/VBZ
conserved/VBN
among/IN
isolates/NNS
of/IN
HIV-2/NN
and/CC
the/DT
closely/RB
related/JJ
simian/JJ
immunodeficiency/NN
virus/NN
,/,
and/CC
transfection/NN
assays/NNS
show/VBP
this/DT
site/NN
to/TO
mediate/VB
HIV-2/NN
enhancer/NN
activation/NN
following/VBG
stimulation/NN
of/IN
monocytic/JJ
but/CC
not/RB
T-cell/NN
lines/NNS
./.
=====
This/DT
is/VBZ
the/DT
first/JJ
description/NN
of/IN
an/DT
HIV-2/NN
enhancer/NN
element/NN
which/WDT
displays/VBZ
such/JJ
monocyte/NN
specificity/NN
,/,
and/CC
no/DT
comparable/JJ
enhancer/NN
element/NN
has/VBZ
been/VBN
clearly/RB
defined/VBN
for/IN
HIV-1/NN
./.
=====
While/IN
a/DT
nuclear/JJ
factor/NN
(/(
s/NNS
)/)
from/IN
both/CC
peripheral/JJ
blood/NN
monocytes/NNS
and/CC
T/NN
cells/NNS
binds/VBZ
the/DT
peri-kappa/NN
B/NN
site/NN
,/,
electrophoretic/JJ
mobility/NN
shift/NN
assays/NNS
suggest/VBP
that/IN
either/CC
a/DT
different/JJ
protein/NN
binds/VBZ
to/TO
this/DT
site/NN
in/IN
monocytes/NNS
versus/CC
T/NN
cells/NNS
or/CC
that/IN
the/DT
protein/NN
recognizing/VBG
this/DT
enhancer/NN
element/NN
undergoes/VBZ
differential/JJ
modification/NN
in/IN
monocytes/NNS
and/CC
T/NN
cells/NNS
,/,
thus/RB
supporting/VBG
the/DT
transfection/NN
data/NNS
./.
=====
Further/RB
,/,
while/IN
specific/JJ
constitutive/JJ
binding/NN
to/TO
the/DT
peri-kappa/NN
B/NN
site/NN
is/VBZ
seen/VBN
in/IN
monocytes/NNS
,/,
stimulation/NN
with/IN
phorbol/NN
esters/NNS
induces/VBZ
additional/JJ
,/,
specific/JJ
binding/NN
./.
=====
Understanding/VBG
the/DT
monocyte-specific/JJ
function/NN
of/IN
the/DT
peri-kappa/NN
B/NN
factor/NN
may/MD
ultimately/RB
provide/VB
insight/NN
into/IN
the/DT
different/JJ
role/NN
monocytes/NNS
and/CC
T/NN
cells/NNS
play/VBP
in/IN
HIV/NN
pathogenesis/NN
./.